Clinical Trials Directory

Trials / Completed

CompletedNCT02442219

A Blood Based Diagnostic Test for Coeliac Disease

Status
Completed
Phase
Study type
Observational
Enrollment
144 (estimated)
Sponsor
Oslo University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Persons with coeliac disease treated with a gluten free diet will be asked to give blood for a new diagnostic blood test. In this test investigators will use multimerized HLA bound to different gliadin-peptides (tetramer) and with the help of a flow-cytometer identify (along with other relevant T-cell-markers) gluten specific T-cells. Investigators believe that these cells will be present in persons with coeliac disease regardless of gluten-intake. Investigators will compare their findings with two control groups; Persons on a gluten free diet where celiac disease is excluded (gluten sensitive group) and persons on a gluten containing diet (healthy control group). In the initial and main study investigators will look at HLA DQ2.5 individuals, which comprise \>90% of all persons with coeliac disease.

Conditions

Timeline

Start date
2015-02-01
Primary completion
2025-07-28
Completion
2025-07-28
First posted
2015-05-13
Last updated
2025-07-30

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT02442219. Inclusion in this directory is not an endorsement.